This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.The long-term objective of the proposed research is to characterize how inherent conformational dynamics of the protein tyrosine phosphatase (PTPase) PRL-1 are stabilized by modification and how modification influences phosphatase activity and cellular function. PRLs were originally identified as early response genes that promote liver regeneration in rats after partial hepatectomy. More recently, over-expression of these enzymes was found to trigger metastasis and promote tumor formation. In each case phosphatase activity is required, but the protein is localized to a unique cellular location, making it critical to identify biochemical switches that direct differential cellular localization and outcomes. Signaling is accomplished through transient, specific interactions driven by changes in structure, which are often influenced by chemical modification. These modifications act as switches in molecular function, controlling important biological processes. The specific role of PRL-1 in regulating signals related to cell growth has not been determined, nor is it known how PRL-1 itself is regulated. Standard heteronuclear solution NMR methods will be used to assign chemical shift resonances and obtain restraints for structure calculations. Relaxation analysis will be used to characterize the dynamic motion of backbone amides in the protein and provide information about conformational changes involved in interconversion between the open and closed states, which are regulated by the redox state of the active site Cys. The affect of Tyr phosphorylation on PRL-1 structure and activity will also be examined with respect to the two states. Understanding how PRL-1 activity is regulated by disulfide formation and post-translational modification will provide critical details to identify which conformation of PRL-1 to target for drug design.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biotechnology Resource Grants (P41)
Project #
5P41RR002301-22
Application #
7598730
Study Section
Special Emphasis Panel (ZRG1-BCMB-E (40))
Project Start
2007-03-01
Project End
2008-02-29
Budget Start
2007-03-01
Budget End
2008-02-29
Support Year
22
Fiscal Year
2007
Total Cost
$980
Indirect Cost
Name
University of Wisconsin Madison
Department
Biochemistry
Type
Schools of Earth Sciences/Natur
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Dominguez, Eddie; Zarnowski, Robert; Sanchez, Hiram et al. (2018) Conservation and Divergence in the Candida Species Biofilm Matrix Mannan-Glucan Complex Structure, Function, and Genetic Control. MBio 9:
Franco, Aldo; Dovell, Sanaz; Möller, Carolina et al. (2018) Structural plasticity of mini-M conotoxins - expression of all mini-M subtypes by Conus regius. FEBS J 285:887-902
Wales, Jessica A; Chen, Cheng-Yu; Breci, Linda et al. (2018) Discovery of stimulator binding to a conserved pocket in the heme domain of soluble guanylyl cyclase. J Biol Chem 293:1850-1864
Travers, Timothy; López, Cesar A; Van, Que N et al. (2018) Molecular recognition of RAS/RAF complex at the membrane: Role of RAF cysteine-rich domain. Sci Rep 8:8461
Thomas, Nathan E; Wu, Chao; Morrison, Emma A et al. (2018) The C terminus of the bacterial multidrug transporter EmrE couples drug binding to proton release. J Biol Chem 293:19137-19147
Assadi-Porter, Fariba M; Radek, James; Rao, Hongyu et al. (2018) Multimodal Ligand Binding Studies of Human and Mouse G-Coupled Taste Receptors to Correlate Their Species-Specific Sweetness Tasting Properties. Molecules 23:
Wijayatunga, Nadeeja N; Sams, Valerie G; Dawson, John A et al. (2018) Roux-en-Y gastric bypass surgery alters serum metabolites and fatty acids in patients with morbid obesity. Diabetes Metab Res Rev 34:e3045
Assadi-Porter, Fariba M; Reiland, Hannah; Sabatini, Martina et al. (2018) Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression. Int J Mol Sci 19:
Selen Alpergin, Ebru S; Bolandnazar, Zeinab; Sabatini, Martina et al. (2017) Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3-iodothyronamine. Physiol Rep 5:
Mong, Surin K; Cochran, Frank V; Yu, Hongtao et al. (2017) Heterochiral Knottin Protein: Folding and Solution Structure. Biochemistry 56:5720-5725

Showing the most recent 10 out of 613 publications